Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History DSGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics DSGN

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Design Therapeutics Inc

DSGN
Current price
3.98 USD -0.04 USD (-1.00%)
Last closed 4.02 USD
ISIN US25056L1035
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 228 210 176 USD
Yield for 12 month -1.73 %
1Y
3Y
5Y
10Y
15Y
DSGN
21.11.2021 - 28.11.2021

Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California. Address: 6005 Hidden Valley Road, Carlsbad, CA, United States, 92011

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.33 USD

P/E Ratio

Dividend Yield

Financials DSGN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures DSGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-537 000 USD

Current Quarter

Last Quarter

EBITDA -67 789 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -16.56 %
PEG Ratio
Return On Equity TTM -22.59 %
Wall Street Target Price 7.33 USD
Revenue TTM 33 000 USD
Book Value 4.02 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -49 926 000 USD
Earnings per share -0.99 USD
Diluted Eps TTM -0.99 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation DSGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 11 004.35
Price Sales TTM 22 642.01
Enterprise Value EBITDA -0.84
Price Book MRQ 1.00

Technical Indicators DSGN

For 52 Weeks

2.60 USD 7.77 USD
50 Day MA 3.81 USD
Shares Short Prior Month 3 651 254
200 Day MA 4.75 USD
Short Ratio 39.67
Shares Short 3 619 433
Short Percent 9.75 %